We are live on ! Find out more
Dmitry Balyasny

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B Turnover 42.78%
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$3.01B
Cap. Flow %
-3.76%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.95%
2 Technology 12.69%
3 Industrials 10%
4 Consumer Discretionary 7.97%
5 Healthcare 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AGX icon
2876
PUT
Argan
AGX
$3.89B
– –
-63,200
Closed -$34.4M –
AIRR icon
2877
First Trust RBA American Industrial Renaissance ETF
AIRR
$7.95B
– –
-52,700
Closed -$5.84M –
AIRS icon
2878
CALL
AirSculpt Technologies
AIRS
$38.5M
– –
-614,600
Closed -$1.74M –
AIRS icon
2879
AirSculpt Technologies
AIRS
$38.5M
– –
-2,326,690
Closed -$6.58M –
AL icon
2880
DELISTED
Air Lease Corp
AL
– –
-1,064,604
Closed -$69.1M –
ALHC icon
2881
Alignment Healthcare
ALHC
$1.54B
– –
-93,678
Closed -$1.65M –
ALLO icon
2882
Allogene Therapeutics
ALLO
$359M
– –
-1,182,816
Closed -$2.89M –
ALTO icon
2883
Alto Ingredients
ALTO
$290M
– –
-11,998
Closed -$58.1K –
AM icon
2884
Antero Midstream
AM
$8.97B
– –
-24,876
Closed -$567K –
AMBA icon
2885
Ambarella
AMBA
$2.58B
– –
-289,849
Closed -$14.9M –
AMN icon
2886
AMN Healthcare
AMN
$1.4B
– –
-69,686
Closed -$1.28M –
AMRC icon
2887
Ameresco
AMRC
$1.15B
– –
-227,505
Closed -$5.8M –
ANAB icon
2888
AnaptysBio
ANAB
$1.39B
– –
-4,905
Closed -$272K –
ANF icon
2889
Abercrombie & Fitch
ANF
$6.35B
– –
-8,695
Closed -$738K –
APG icon
2890
APi Group
APG
$17.4B
– –
-626,059
Closed -$25.4M –
APLS icon
2891
DELISTED
Apellis Pharmaceuticals
APLS
– –
-1,917,501
Closed -$77.1M –
AQN icon
2892
CALL
Algonquin Power & Utilities
AQN
$4.25B
– –
-500,000
Closed -$3.06M –
ARDC icon
2893
Are Dynamic Credit Allocation Fund
ARDC
$276M
– –
-115,080
Closed -$1.4M –
ARGX icon
2894
argenx
ARGX
$58.3B
– –
-13,111
Closed -$9.6M –
ARI icon
2895
Apollo Commercial Real Estate
ARI
$298M
– –
-276,134
Closed -$2.92M –
ARKO icon
2896
ARKO Corp
ARKO
$445M
– –
-59,991
Closed -$334K –
ARLO icon
2897
Arlo Technologies
ARLO
$1.33B
– –
-12,905
Closed -$184K –
EFOR icon
2898
Everforth Inc
EFOR
$1.41B
– –
-62,261
Closed -$2.41M –
ASHR icon
2899
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.29B
– –
-368,500
Closed -$12M –
ASHR icon
2900
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.29B
– –
-10,100
Closed -$330K –

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.